Wondr Medical | Search

Log In Sign Up

Sharing knowledge of renal denervation (RDN) as a new device-based therapy for control of raised blood pressure

Jason Fontana 32 followers 8 videos

VP Renal Denervation & Marketing Leader, Medtronic.

Flavio Ribichini 53 followers 35 videos

Prof. Flavio L. Ribichini is Full Professor of Cardiovascular Medicine and Director of the Division of Cardiovascular Medicine of the University of Verona, where he has served since 2006.
Dedicated full time to Interventional Cardiology since...

Costas Tsioufis 36 followers 18 videos

Dr. Tsioufis, Professor of Cardiology, National and Kapodistrian University of Athens, Director of the Hypertension Unit, 1st Cardiology Clinic, Hippokration Hospital, Athens, Greece. Interventional Cardiologist and Hypertension Specialist.

What is the future of Renal Denervation?

Markus Schlaich 13 followers 3 videos

Prof Markus Schlaich is a renal physician and a European Society of Hypertension (ESH) accredited hypertension specialist with a strong background in clinical research. His main scientific interests focus on pathophysiologic aspects of...

Fausto Pinto 34 followers 22 videos

Fausto J Pinto graduated at Lisbon School of Medicine, Univ Lisbon, did his cardiology training at University Hospital Santa Maria in Lisbon and Stanford University Medical Center, CA, USA, where he was also junior Faculty. He is the Dean of the...

Which evidence is most important to you to support the use of RDN in clinical practice?

¿Funciona la RDN junto con otra medicación antihipertensiva?

What team is necessary to set up an RDN service?

How is RDN best implemented into clinical practice?

What effect size should I expect from RDN, and what effect could that effect (reduction in blood pressure) have on cardiovascular morbidity and mortality?